Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites.
about
Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) elementA small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in miceHERV-K(HML-2), a seemingly silent subtenant - but still waters run deep.The νSaα Specific Lipoprotein Like Cluster (lpl) of S. aureus USA300 Contributes to Immune Stimulation and Invasion in Human Cells.Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related SequencesGeneration, Characterization and Application of Antibodies Directed against HERV-H Gag Protein in Colorectal SamplesIdentification of Protease Specificity by Combining Proteome-Derived Peptide Libraries and Quantitative ProteomicsHuman endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1.Identification of late assembly domains of the human endogenous retrovirus-K(HML-2).Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system.The Intracellular Cholesterol Transport Inhibitor U18666A Inhibits the Exosome-Dependent Release of Mature Hepatitis C Virus.ERVK polyprotein processing and reverse transcriptase expression in human cell line models of neurological disease.The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells.The cellular antiviral restriction factor tetherin does not inhibit poxviral replicationMolecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity.
P2860
Q28743663-AD3BCBB6-D1EE-40C5-9EF0-56D7BD6D1D70Q30938741-49DBD6FC-7A64-41D5-BBFB-8AFBF1AC95C6Q34511101-29D40E0B-953B-427A-B305-230C46FC7CEEQ35666042-160E556C-9911-4836-9F63-4B214DDEE350Q35758600-D3A48B25-45C1-46C6-A4EE-15E29939F3E5Q36000670-E14553EC-2874-46D1-9BA1-996EBEC19A14Q36001454-E6FB0B89-BAFE-4E42-858B-8612FFC70E09Q36276266-E1CA0DBA-CEB2-4AE7-A622-C2973A42F003Q37418079-FEB102BB-A504-4B7A-A421-734A5F80E4D2Q37682344-BEE48F13-FFC5-4774-9B29-5B55D10CB857Q38735167-4B711D8A-6545-4DB2-B740-526F060F38B9Q38917776-26BCD016-A499-4FC4-BF1F-5F32B8ED7EDEQ39212690-2620A499-29F2-4641-AA87-90235E407522Q39441885-3B77D925-D32B-4904-AAD6-B2F7F5065787Q40226566-8F3FB6CA-D8C9-4F36-AAFC-BBAAE30D9754
P2860
Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Characterization of the human ...... on of protease cleavage sites.
@en
Characterization of the human ...... on of protease cleavage sites.
@nl
type
label
Characterization of the human ...... on of protease cleavage sites.
@en
Characterization of the human ...... on of protease cleavage sites.
@nl
prefLabel
Characterization of the human ...... on of protease cleavage sites.
@en
Characterization of the human ...... on of protease cleavage sites.
@nl
P2093
P2860
P356
P1433
P1476
Characterization of the human ...... ion of protease cleavage sites
@en
P2093
Barbara S Schnierle
Benjamin Kraus
Klaus Boller
P2860
P2888
P356
10.1186/1742-4690-8-21
P577
2011-03-23T00:00:00Z
P5875
P6179
1001512498